Short answer: Gumitide gets the commercial side right — one-time billing, a real 60-day window, US manufacture in a registered facility, no stimulants. Where it falls down is the substance, and that combination is why our score sits at 2.8 out of 5.
What the score rewards
A format people will actually stick with. Adherence is underrated, and a gummy beats a capsule nobody takes — the commercial terms here are genuinely clean.
What the score penalizes
The headline ACV weight-loss claim rests on a study that no longer exists in the scientific record. The BHB component only makes sense in a ketogenic context the marketing never mentions. And the 525mg proprietary blend means nobody outside the company can verify what they're paying for.
Why this is an editorial assessment, not a measurement
The 2.8/5 rating is this publication's own editorial assessment based on published research, brand-disclosed labelling and third-party reporting — opinion, not measurement.
Check current Gumitide Gummies pricing
See bundle options before you decide.
Check Price